RESULTS OF COLLABORATIVE STUDY FOR TISSUE TYPING QUALITY CONTROL

Autor: V. Y. Abramov, O. V. Gulidova, L. L. Lebedeva, L. K. Popova, E. N. Matsulenko, N. N. Kaluzhina

Publikováno v: Вестник трансплантологии и искусственных органов, Vol 12, Iss 3, Pp 89-93 (2010)

HLA molecules appear to be the principal target of immune allorecognition. The efficiency of transplant directly depends on coincidence of the data obtained by different HLA laboratories. This study discusses the results produced by 12 tissue typing

Externí odkaz: https://doaj.org/article/8d1f14760cdf4ba19d92366e2f4036b6

Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: Preliminary results

Autor: G A Novichkova, M A Maschan, I P Shipitsyna, Yu V Skvortsova, M I Persiantseva, L L Lebedeva, V O Bobrynina, D D Baidildina, O V Goronkova, G G Solopova, L A Khachatryan, U N Petrova, E V Suntsova, I I Kalinina, V V Sinitsyna, E V Skorobogatova, D N Balashov, Z M Dyshlevaya, L N Shelikhova, E E Kurnikova, P E Trakhtman, A A Maschan

Publikováno v: Терапевтический архив, Vol 82, Iss 7, Pp 41-47 (2010)

Aim. To analyze the efficiency of transplantation of the bone marrow from a HLA-compatible unrelated donor and continued immunosuppressive therapy (IST) in children with aplastic anemia (AA) unresponsive to 2 courses of IST. Subjects and methods. The

Externí odkaz: https://doaj.org/article/a539b74b2830479ca8268ed25335826e

[Importance of the immunogenetic factors in the development of glutensensitive celiac disease in adults of Moscow region]

Autor: T V, Pukhlikova, L L, Lebedeva, E A, Sabel'nikova, T A, Astrelina, M V, Iakovleva

Publikováno v: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (3)

The study examined the genetic predisposition to the development of glutensensitive celiac disease (CD). Were analyzed samples of peripheral blood of 17 adult patients diagnosed with CD, as well as samples of umbilical cord blood of 1700 newborns of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::231b20db7a62604a35ca3faf1176f1d0
https://pubmed.ncbi.nlm.nih.gov/21695948

Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane.

Autor: Martin M; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: mmartin@geicam.org., Campone M; Medical Oncology Department, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Bondarenko I; Oncology and Medical Radiology Department, Dnipropetrovsk Medical Academy, City Multidisciplinary Clinical Hospital No. 4, Dnipropetrovsk, Ukraine., Sakaeva D; State Budgetary Healthcare Institution, Republican Clinical Oncology Dispensary of MoH of Bashkortostan Republic, Ufa, Russia., Krishnamurthy S; Department of Surgical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India., Roman L; Leningrad Regional Oncology Dispensary, St Petersburg., Lebedeva L; Department of Chemotherapy, Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk, Russia., Vedovato JC; Clinical Development Oncology, Oncology Innovation Unit, Institut de Recherche Pierre Fabre, Toulouse, France., Aapro M; Cancer Center, Clinique de Genolier, Genolier, Switzerland.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 May 01; Vol. 29 (5), pp. 1195-1202.